For women of childbearing potential experiencing severe nausea, pregnancy testing may be warranted, as semaglutide is not recommended during pregnancy
STEP 5 Two-Year Safety Results In the STEP 5 trial involving 304 participants (152 receiving semaglutide, 152 receiving placebo), gastrointestinal adverse events occurred in 82.2% of the semaglutide group versus 53.9% of the placebo group over the two-year period
Piccola molecola non peptidica
Mechanism of Action Semaglutide functions by: Enhancing Insulin Secretion : In response to elevated blood sugar levels, semaglutide stimulates insulin release from the pancreas, aiding in glucose regulation
It functions to help regulate glucose levels in a manner similar to the GLP-1 hormone that your stomach naturally releases after eating
LegitScript certification means Brightmeds has been independently verified for compliance with federal and state pharmacy regulations